KIMS NSE filing

Krishna Institute of Medical Sciences (KIMS) Holds 23rd Annual General Meeting

The RealCase readLow impact Neutral

Why it matters

The AGM primarily involved the adoption of financial statements and re-appointment of directors, along with other routine audit-related appointments, which are standard annual corporate governance activities and do not indicate a significant change in the company's operations or financial outlook.

The market read

The announcement details the procedural aspects and standard resolutions of the 23rd Annual General Meeting, which are routine corporate governance activities without immediate positive or negative financial implications.

* Krishna Institute of Medical Sciences Limited (KIMS) held its 23rd Annual General Meeting (AGM) on August 29, 2025, at 4:00 PM (IST) via video conferencing (VC) and other audio-visual means, concluding at 5:30 PM (IST). * The meeting was attended by 60 members and was presided over by Dr. Bhaskara Rao Bollineni, Chairman & Managing Director, alongside other directors including Dr. Abhinay Bollineni (Director & CEO). * Key attendees also included Mr. Sachin Ashok Salvi (Chief Financial Officer) and Ms. Nagajayanthi J. R (Company Secretary & Compliance Officer). * The company provided an e-voting facility for all resolutions, with M/s. IKR & Associates, Practicing Company Secretaries, appointed as the Scrutinizer for the voting process. * The following ordinary business resolutions, as per the Notice dated May 12, 2025, were tabled and discussed: * Adoption of the financial statements, including consolidated financial statements, for the financial year ended March 31, 2025, along with the reports of the Board of Directors and Auditors. * Re-appointment of Dr. Abhinay Bollineni (DIN No. 01681273) as a Director, who retires by rotation. * Ratification of the remuneration payable to M/s. Sagar & Associates, Cost Auditors, for the financial year 2025-26. * Appointment of M/s IKR & Associates, Practicing Company Secretaries, as the Secretarial Auditors of the Company. * Shareholders were given the opportunity to ask questions, and clarifications were provided. * The detailed voting results (from remote e-voting and e-voting at the AGM) and the Scrutinizer’s Report will be submitted to the exchanges and published on the company's website in due course.

Filing to action

What to do with a filing like this

Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.

View original filing